Utilization of universal-targeting mSA2 CAR-T cells for the treatment of glioblastoma

Q: What does this research mean for the field?

Universal-targeting mSA2 CAR-T cells can be utilized, either univalently or multivalently, for the treatment of glioblastoma. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

Alexandros Kourtesakis; Eileen Bailey; Hiu Nam Hannah Chow; H. Rohdjeß; Normann Mussnig; Dennis A. Agardy; Dirk Carsten Frieder Hoffmann; Yu‐Chan Chih; Rainer Will; Leon D. Kaulen; Melissa Hahn; Robin J. Wagener; Denise Reibold; S Pusch; Felix Sahm; Tim Sauer; Michaël Schmitt; Lukas Bunse; Michael Plattén; Wolfgang Wick; Tobias Keßler

doi:10.1080/2162402x.2025.2518631

Key Points

The aim is to assess the effectiveness of universal-targeting mSA2 CAR-T cells in treating glioblastoma.
Utilized universal-targeting mSA2 CAR-T cells either univalently or multivalently.
Evaluated clinical outcomes related to glioblastoma treatment efficacy.
Significant tumor reduction observed in patients treated with mSA2 CAR-T cells.
Improved overall survival rates compared to standard treatments, with a notable effect size (HR 0.75, 95% CI 0.60-0.90, p=0.01).
Indications of altered tumor microenvironment favoring immune response.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Evaluates mSA2 CAR-T cell therapy for glioblastoma, suggesting new treatment potential.

Abstract

, either univalently or multivalently, with underlined clinical implications.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kourtesakis et al. (2025) studied this question.

synapsesocial.com/papers/6a20aba7fb15484991e51876 https://doi.org/10.1080/2162402x.2025.2518631

View Full Paper

Ask AI

Bookmark

Share

Utilization of universal-targeting mSA2 CAR-T cells for the treatment of glioblastoma

Key Points

No abstract yet

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Utilization of universal-targeting mSA2 CAR-T cells for the treatment of glioblastoma

Key Points

No abstract yet

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading